Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:34 AM ET

Sponsor Check › Person

No photo found yet (own website and image search run after this page is viewed)

Robert Shorr

Named as an officer, director or promoter on SEC Form D filings · NY, NJ · Mar 13, 2013 → Jan 21, 2015

2deals (issuers)

$16.7Mreported sold

77investors

7Form D filings

2013–2015years on file

Follow this person Look further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:27 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Robert Shorr is listed as an executive officer and director on 7 SEC Form D filings by 2 issuers between Jul 2012 and Jan 2015: BRAINSTORM CELL THERAPEUTICS INC. (New York, NY — biotechnology — 2012–2015; $10.5M reported sold to 11 investors) and CORNERSTONE PHARMACEUTICALS INC (Cranbury,, NJ — pharmaceuticals — 2013–2014; $6.18M reported sold to 66 investors).

What this means 2 separate companies raised money with this person listed as executive officer and director, over about 3 years. Across those companies the filings report $16.7M sold in total.

Listed alongside Alon Pinkas (4 shared filings), Chaim Lebovits (4 shared filings), Chen Schor (4 shared filings), Irit Arbel (4 shared filings), Liat Sossover (4 shared filings) and 16 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 7 public filings for Robert Shorr and found 8 differences, 3 worth asking the sponsor about: Regulator action naming a team member: Howard S. Jonas (Sep 25, 2024); 8 bankruptcy cases name the subject or team members; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Robert Shorr has not run yet — it is joining a line of 56,838 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:27 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Robert Shorr..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

Robert D. Shorr and Norma E. Shorr closed

United States Bankruptcy Court, D. Rhode Island · No. 1:09-bk-14427 · Filed Nov 11, 2009 · Closed Feb 22, 2010

Role of Robert D. Shorr and Norma E. Shorr: Debtor · Outcome: Case closed 2010-02-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same full name (rare in federal dockets); court in RI (not a filing state)

Pamela Jane Shorr and Robert Shorr closed

United States Bankruptcy Court, E.D. Pennsylvania · No. 07-10253 · Filed Jan 12, 2007 · Closed Jul 24, 2007

Role of Robert Shorr: Debtor · Outcome: Case closed 2007-07-24 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same full name (rare in federal dockets); court in PA (not a filing state)

Robert D. Shorr and Norma E. Shorr closed

United States Bankruptcy Court, D. Rhode Island · No. 1:00-bk-12669 · Filed Aug 2, 2000 · Closed Jan 17, 2001

Role of Robert D. Shorr and Norma E. Shorr: Debtor · Outcome: Case closed 2001-01-17 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same full name (rare in federal dockets); court in RI (not a filing state)

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:27 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

8 differences found between the filings for Robert Shorr — 3 worth asking about (compared 7 filings on Oct 24, 2026)

Worth asking · Sep 25, 2024

Regulator action naming a team member: Howard S. Jonas (Sep 25, 2024)

A ap release dated Sep 25, 2024 names Howard S. Jonas (listed on the same filings). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Howard S. Jonas ↗Howard S. Jonas — PartnerFacts page ↗

Sources

Howard S. Jonas ↗ (Sep 25, 2024)
Howard S. Jonas — PartnerFacts page ↗

Worth asking · Apr 6, 1989 – Feb 1, 2017

8 bankruptcy cases name the subject or team members

Bankruptcy case: Robert D. Shorr and Norma E. Shorr — filed Nov 11, 2009 · Bankruptcy case: Pamela Jane Shorr and Robert Shorr — filed Jan 12, 2007 · Bankruptcy case: Robert D. Shorr and Norma E. Shorr — filed Aug 2, 2000 · Bankruptcy case: Mordechai Friedman — filed Sep 20, 2016 · Bankruptcy case: Mordechai Friedman — filed Oct 26, 2015 · and 3 more

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. Rhode Island ↗Docket · United States Bankruptcy Court, E.D. Pennsylvania ↗Docket · United States Bankruptcy Court, D. Rhode Island ↗Docket · United States Bankruptcy Court, S.D. New York ↗

Sources

Docket · United States Bankruptcy Court, D. Rhode Island ↗ (Nov 11, 2009)
Docket · United States Bankruptcy Court, E.D. Pennsylvania ↗ (Jan 12, 2007)
Docket · United States Bankruptcy Court, D. Rhode Island ↗ (Aug 2, 2000)
Docket · United States Bankruptcy Court, S.D. New York ↗ (Sep 20, 2016)
Mordechai Friedman — PartnerFacts page ↗
Docket · United States Bankruptcy Court, S.D. New York ↗ (Oct 26, 2015)
Docket · United States Bankruptcy Court, D. New Jersey ↗ (Apr 13, 2005)
Joseph A. Stern — PartnerFacts page ↗

Worth asking · Mar 7, 2014

56% of the money raised went to insiders — CORNERSTONE PHARMACEUTICALS INC

The Mar 7, 2014 Form D reports $3,311,000 sold and $1,850,000 of the proceeds used for payments to officers, directors or promoters.

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Mar 7, 2014 ↗CORNERSTONE PHARMACEUTICALS INC — PartnerFacts page ↗

Sources

Form D · Mar 7, 2014 ↗ (Mar 7, 2014)
CORNERSTONE PHARMACEUTICALS INC — PartnerFacts page ↗ (Mar 7, 2014)

Note · Feb 26, 2013 – Jan 21, 2015

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — BRAINSTORM CELL THERAPEUTICS INC. (latest filing Jan 21, 2015) · No amendment in the last 12 months on an offering that may still be open — BRAINSTORM CELL THERAPEUTICS INC. (latest filing May 9, 2014) · No amendment in the last 12 months on an offering that may still be open — CORNERSTONE PHARMACEUTICALS INC (latest filing Mar 7, 2014) · No amendment in the last 12 months on an offering that may still be open — CORNERSTONE PHARMACEUTICALS INC (latest filing Mar 29, 2013)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jan 21, 2015 ↗BRAINSTORM CELL THERAPEUTICS INC. — PartnerFacts page ↗Form D · May 9, 2014 ↗Form D · Mar 7, 2014 ↗

Sources

Form D · Jan 21, 2015 ↗ (Jan 21, 2015)
BRAINSTORM CELL THERAPEUTICS INC. — PartnerFacts page ↗ (Aug 9, 2019)
Form D · May 9, 2014 ↗ (May 9, 2014)
Form D · Mar 7, 2014 ↗ (Mar 7, 2014)
CORNERSTONE PHARMACEUTICALS INC — PartnerFacts page ↗ (Mar 7, 2014)
Form D/A · Mar 29, 2013 ↗ (Mar 29, 2013)

Note · Mar 13, 2013 – Mar 29, 2013

Minimum investment changed between filings — CORNERSTONE PHARMACEUTICALS INC

The Mar 13, 2013 filing lists a minimum of $11,000; the Mar 29, 2013 Form D/A lists $5,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Mar 13, 2013 ↗Form D/A (later) · Mar 29, 2013 ↗CORNERSTONE PHARMACEUTICALS INC — PartnerFacts page ↗

Sources

Form D (earlier) · Mar 13, 2013 ↗ (Mar 13, 2013)
Form D/A (later) · Mar 29, 2013 ↗ (Mar 29, 2013)
CORNERSTONE PHARMACEUTICALS INC — PartnerFacts page ↗ (Mar 7, 2014)

Note · Jul 27, 2012 – May 9, 2014

Reported revenue range changed between filings — BRAINSTORM CELL THERAPEUTICS INC.

"No Revenues" (Jul 27, 2012); then "Decline to Disclose" (May 9, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jul 27, 2012 ↗Form D · May 9, 2014 ↗BRAINSTORM CELL THERAPEUTICS INC. — PartnerFacts page ↗

Sources

Form D · Jul 27, 2012 ↗ (Jul 27, 2012)
Form D · May 9, 2014 ↗ (May 9, 2014)
BRAINSTORM CELL THERAPEUTICS INC. — PartnerFacts page ↗ (Aug 9, 2019)

Note · Jul 1, 2014 – Jan 21, 2015

Address moved from New York, NY to Hackensack, NJ — BRAINSTORM CELL THERAPEUTICS INC.

The people listed on the Jul 1, 2014 filing give New York, NY; on the Jan 21, 2015 filing they give Hackensack, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 1, 2014 ↗Form D · Jan 21, 2015 ↗BRAINSTORM CELL THERAPEUTICS INC. — PartnerFacts page ↗

Sources

Form D · Jul 1, 2014 ↗ (Jul 1, 2014)
Form D · Jan 21, 2015 ↗ (Jan 21, 2015)
BRAINSTORM CELL THERAPEUTICS INC. — PartnerFacts page ↗ (Aug 9, 2019)

Note · Jul 27, 2012 – Jan 21, 2015

Robert Shorr is listed with 2 different address states: NY, NJ

NY on 3 filings (Jul 27, 2012 to Jul 1, 2014); NJ on 4 filings (Mar 13, 2013 to Jan 21, 2015).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jul 27, 2012 ↗Form D · Mar 13, 2013 ↗

Sources

Form D · Jul 27, 2012 ↗ (Jul 27, 2012)
Form D · Mar 13, 2013 ↗ (Mar 13, 2013)

What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 6 offerings report sales commissions totalling $1,542,116; 0 report finder's fees; 1 reports proceeds to related persons totalling $1,850,000.

Offering (latest filing)	Sales commissions	Finder's fees	To insiders	Paid to sell it	Source
Jan 21, 2015 D BRAINSTORM CELL THERAPEUTICS INC. File 021-232585	$817,616	$0	$0	Maxim Partners LLC BrokerCheck CRD 120708 ↗ via Maxim Group LLC (CRD 120708 ↗)	EDGAR ↗
Jul 1, 2014 D BRAINSTORM CELL THERAPEUTICS INC. File 021-220150	$724,500	$0	$0	Maxim Group LLC BrokerCheck CRD 120708 ↗ via Maxim Group LLC (CRD 120708 ↗)	EDGAR ↗
May 9, 2014 D BRAINSTORM CELL THERAPEUTICS INC. File 021-217111	$0	$0	$0	None listed on this filing	EDGAR ↗
Mar 7, 2014 D CORNERSTONE PHARMACEUTICALS INC File 021-213135	$0	$0	$1,850,000	N/A no CRD number reported	EDGAR ↗
Mar 29, 2013 D/A CORNERSTONE PHARMACEUTICALS INC File 021-193213	$0	$0	$0	None listed on this filing	EDGAR ↗
Jul 27, 2012 D BRAINSTORM CELL THERAPEUTICS INC. File 021-181882	$0	$0	$0	None listed on this filing	EDGAR ↗

How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Robert Shorr on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

BRAINSTORM CELL THERAPEUTICS INC.

New York, NY · Jul 27, 2012 → Jan 21, 2015 · 4 filings

Jan 21, 2015 · D · $0 sold of Indefinite · 8 investors · min. No minimum reported · role: Director EDGAR ↗
Jul 1, 2014 · D · $10,500,000 sold of $10,500,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
May 9, 2014 · D · $1,632,689 sold of $2,470,590 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
Jul 27, 2012 · D · $206,910 sold of $206,910 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10.5M from 11 investors as of the latest filing. Robert is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

CORNERSTONE PHARMACEUTICALS INC

Cranbury,, NJ · Mar 13, 2013 → Mar 7, 2014 · 3 filings

Mar 7, 2014 · D · $3,311,000 sold of $7,500,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Mar 29, 2013 · D/A · $4,565,110 sold of $6,000,000 · 25 investors · min. $5,000 · role: Executive Officer, Director EDGAR ↗
Mar 13, 2013 · D · $3,768,100 sold of $6,000,000 · 16 investors · min. $11,000 · role: Executive Officer, Director EDGAR ↗

Raised $6.18M from 66 investors (82% of the $7.5M target) as of the latest filing. Robert is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Robert 21

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Management entity